Sunobinop tosylate is under clinical development by Imbrium Therapeutics and currently in Phase II for Insomnia. According to GlobalData, Phase II drugs for Insomnia have a 44% phase transition ...

News, August 07, 2006 International Approvals: Sutent and Nexavar The EU has granted conditional approval for sunitinib malate capsules (Sutent) and it has approved sorafenib tosylate tablets ...